Rethinking Breast-Cancer Treatment: How Doctors and Patients Are Navigating Decisions in 2026

Why Doctors Are Rethinking Breast-Cancer Treatment | TIME

Dr. Steven J. Katz, a professor at the College of Michigan, highlights that most women feel healthy at the time of diagnosis. With nearly all women diagnosed between ages 55 and 64, mortality isn’t top of mind. However, inevitably, it comes up. Katz explains: “They are well and told they are sick. And they are told they’re going to have to get really sick to get well.”

Women describe the moment in phrases like: “I literally went into shock.” or “I had been blindsided.” Even remembering exact times: “I don’t remember what we talked about, but I remember it was 4:01 pm.”

This is a challenging position to make a life-altering decision, and many women decide within days, says Katz. UCSF’s Esserman notes: “It’s time to ask, what happens if we do nothing immediately? Let us not panic. There’s no evidence to support surgery in 2 days.”

Newer and More Effective Tools

Advances like Oncotype DX help doctors determine if patients will respond to chemotherapy. Another test, Oncotype DX DCIS, helps evaluate risk of recurrence and guides radiotherapy decisions.

Important: While tools are improving, many clinicians caution that active surveillance still lacks randomized prospective trial evidence—the gold standard for widespread adoption.

Key Studies and Initiatives

Study / Program	Focus	Location / Scope
LORIS Study	Randomized trial on DCIS management	UK, 900 women
Knowledge Study	Annual vs personalized screening	California, USA
DCIS Registry	Track outcomes of active surveillance	University of California medical centers
Retrospective Study by Hwang	Evaluate active surveillance vs standard care	USA

Patient-Centered Decision Making

Katz’s studies highlight a natural tendency of patients to defer to doctors when facing the “C word.” The choice of physician, their communication, and how they present options is critical. Many women want to return to normal quickly, but this can clash with the best medical approach.

Pro Tip: For patients navigating breast cancer decisions, consider reading related posts on provocative breast-cancer awareness campaigns to understand how patient perception and societal messaging interact.

FAQ — Rethinking Breast-Cancer Treatment

Q1: Should all DCIS patients undergo immediate surgery?
A: Not necessarily. Some may be candidates for active surveillance, guided by genomic testing and physician recommendations.

Q2: What is active surveillance?
A: Monitoring the patient closely without immediate surgery, to intervene only if progression occurs.

Q3: Why are randomized trials important?
A: They provide the highest level of evidence to ensure new approaches are safe and effective.

Patient Perspectives

Many women, like Basila, weigh quality of life and personal risk: “I know life is finite and death inevitable. For me, it came down to the quality of life I want to live.”

Corrections and Updates

Correction: Updated to reflect the correct title from the Dana-Farber/Brigham and Women’s Cancer Center. Early versions misstated which patients would participate in the Knowledge study.

Source: TIME